Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization

Yoshitaka Okuda,1 Masanori Fukumoto,1 Taeko Horie,1 Hidehiro Oku,1 Shinji Takai,2 Toyofumi Nakanishi,3 Kaori Matsuzaki,4 Hiroyuki Tsujimoto,4 Tsunehiko Ikeda1 1Department of Ophthalmology, Osaka Medical College, Osaka, Japan; 2Department of Innovative Medicine, Graduate School of Medicine, Osaka Me...

Full description

Bibliographic Details
Main Authors: Okuda Y, Fukumoto M, Horie T, Oku H, Takai S, Nakanishi T, Matsuzaki K, Tsujimoto H, Ikeda T
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/periocular-injection-of-candesartan-plga-microparticles-inhibits-laser-peer-reviewed-article-OPTH
id doaj-ad84eb589c4a4a2799b83e144de1db28
record_format Article
spelling doaj-ad84eb589c4a4a2799b83e144de1db282020-11-24T23:33:46ZengDove Medical PressClinical Ophthalmology1177-54832018-12-01Volume 13879343368Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularizationOkuda YFukumoto MHorie TOku HTakai SNakanishi TMatsuzaki KTsujimoto HIkeda TYoshitaka Okuda,1 Masanori Fukumoto,1 Taeko Horie,1 Hidehiro Oku,1 Shinji Takai,2 Toyofumi Nakanishi,3 Kaori Matsuzaki,4 Hiroyuki Tsujimoto,4 Tsunehiko Ikeda1 1Department of Ophthalmology, Osaka Medical College, Osaka, Japan; 2Department of Innovative Medicine, Graduate School of Medicine, Osaka Medical College, Osaka, Japan; 3Department of Clinical and Laboratory Medicine, Osaka Medical College, Osaka, Japan; 4Research and Development Division, Hosokawa Micron Corporation, Osaka, Japan Purpose: Microparticle technology enables local administration of medication. The purpose of this study was to examine the inhibitory effect of locally administered candesartan (CAN)-encapsulated microparticles on experimental choroidal neovascularization (CNV). Methods: Laser photocoagulation was used to induce CNV in Brown Norway rats. The rats were pretreated with subconjunctival injections of CAN (5.0 mg/eye) or phosphate buffer saline for 3 days before photocoagulation. The volume of CNV was evaluated 7 days after laser injury using the lectin staining technique. The infiltration of macrophages within the CNV lesion was determined using immunofluorescent staining with an anti-CD68 antibody. mRNA levels of MCP-1, IL1-β and VEGF in the retinal pigment epithelium/choroid complex were determined using quantitative PCR (q-PCR). Results: CNV volume was significantly suppressed by the treatment with CAN compared with that in vehicle-treated eyes (P<0.05, two-tailed Student’s t-test). Subconjunctival injections of CAN decreased the numbers of CD68+ cells in the CNV lesion. The increased mRNA levels of MCP-1, IL1-β, and VEGF induced by photocoagulation was significantly suppressed following the local administration of CAN (P<0.05, two-tailed Student’s t-test). Conclusion: Local administration of CAN inhibited experimentally induced CNV possibly through anti-inflammatory effects. Keywords: age-related macular degeneration, choroidal neovascularization, renin-angiotensin system, candesartan, macrophage, monocyte chemotactic protein 1, poly(lactic-co-glycolic acid)https://www.dovepress.com/periocular-injection-of-candesartan-plga-microparticles-inhibits-laser-peer-reviewed-article-OPTHage-related macular degenerationchoroidal neovascularizationrenin-angiotensin systemcandesartanmacrophagemonocyte chemotactic protein 1poly(lactic-co-glycolic acid)
collection DOAJ
language English
format Article
sources DOAJ
author Okuda Y
Fukumoto M
Horie T
Oku H
Takai S
Nakanishi T
Matsuzaki K
Tsujimoto H
Ikeda T
spellingShingle Okuda Y
Fukumoto M
Horie T
Oku H
Takai S
Nakanishi T
Matsuzaki K
Tsujimoto H
Ikeda T
Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization
Clinical Ophthalmology
age-related macular degeneration
choroidal neovascularization
renin-angiotensin system
candesartan
macrophage
monocyte chemotactic protein 1
poly(lactic-co-glycolic acid)
author_facet Okuda Y
Fukumoto M
Horie T
Oku H
Takai S
Nakanishi T
Matsuzaki K
Tsujimoto H
Ikeda T
author_sort Okuda Y
title Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization
title_short Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization
title_full Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization
title_fullStr Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization
title_full_unstemmed Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization
title_sort periocular injection of candesartan-plga microparticles inhibits laser-induced experimental choroidal neovascularization
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2018-12-01
description Yoshitaka Okuda,1 Masanori Fukumoto,1 Taeko Horie,1 Hidehiro Oku,1 Shinji Takai,2 Toyofumi Nakanishi,3 Kaori Matsuzaki,4 Hiroyuki Tsujimoto,4 Tsunehiko Ikeda1 1Department of Ophthalmology, Osaka Medical College, Osaka, Japan; 2Department of Innovative Medicine, Graduate School of Medicine, Osaka Medical College, Osaka, Japan; 3Department of Clinical and Laboratory Medicine, Osaka Medical College, Osaka, Japan; 4Research and Development Division, Hosokawa Micron Corporation, Osaka, Japan Purpose: Microparticle technology enables local administration of medication. The purpose of this study was to examine the inhibitory effect of locally administered candesartan (CAN)-encapsulated microparticles on experimental choroidal neovascularization (CNV). Methods: Laser photocoagulation was used to induce CNV in Brown Norway rats. The rats were pretreated with subconjunctival injections of CAN (5.0 mg/eye) or phosphate buffer saline for 3 days before photocoagulation. The volume of CNV was evaluated 7 days after laser injury using the lectin staining technique. The infiltration of macrophages within the CNV lesion was determined using immunofluorescent staining with an anti-CD68 antibody. mRNA levels of MCP-1, IL1-β and VEGF in the retinal pigment epithelium/choroid complex were determined using quantitative PCR (q-PCR). Results: CNV volume was significantly suppressed by the treatment with CAN compared with that in vehicle-treated eyes (P<0.05, two-tailed Student’s t-test). Subconjunctival injections of CAN decreased the numbers of CD68+ cells in the CNV lesion. The increased mRNA levels of MCP-1, IL1-β, and VEGF induced by photocoagulation was significantly suppressed following the local administration of CAN (P<0.05, two-tailed Student’s t-test). Conclusion: Local administration of CAN inhibited experimentally induced CNV possibly through anti-inflammatory effects. Keywords: age-related macular degeneration, choroidal neovascularization, renin-angiotensin system, candesartan, macrophage, monocyte chemotactic protein 1, poly(lactic-co-glycolic acid)
topic age-related macular degeneration
choroidal neovascularization
renin-angiotensin system
candesartan
macrophage
monocyte chemotactic protein 1
poly(lactic-co-glycolic acid)
url https://www.dovepress.com/periocular-injection-of-candesartan-plga-microparticles-inhibits-laser-peer-reviewed-article-OPTH
work_keys_str_mv AT okuday periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
AT fukumotom periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
AT horiet periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
AT okuh periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
AT takais periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
AT nakanishit periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
AT matsuzakik periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
AT tsujimotoh periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
AT ikedat periocularinjectionofcandesartanplgamicroparticlesinhibitslaserinducedexperimentalchoroidalneovascularization
_version_ 1725530886702628864